Glioma is the most common and fatal primary brain tumor in human. Long non-coding RNA
(lncRNA), which are characterized by regulation of gene expression and chromatin …

Background: A variety of regulatory approaches including immune modulation have been
explored as approaches to either eradicate antitumor response or induce suppressive …

Background The tumor immune microenvironment is closely related to the malignant
progression and treatment resistance of glioma. Long non-coding RNA (lncRNA) plays a …

Recent studies have demonstrated the utility and superiority of long non-coding RNAs
(lncRNAs) as novel biomarkers for cancer diagnosis, prognosis, and therapy. In the present …

Background Glioblastoma multiforme (GBM) is the most common primary malignant brain
tumor in adults. This study aimed to construct immune-related long non-coding RNAs …

Background Glioblastoma multiforme (GBM) is extensively genetically and transcriptionally
heterogeneous, which poses challenges for classification and management. Long …

Background Glioma is the primary cancer of the central nervous system, and defining the
prognosis of glioma is of great significance in the clinical. The long noncoding RNAs …

Aims The dysregulation of TGF‐β signaling is a crucial pathophysiological process in
tumorigenesis and progression. LncRNAs have diverse biological functions and are …

Long noncoding ribonucleic acids (RNAs; lncRNAs) have been associated with cancer
immunity regulation. However, the roles of immune cell-specific lncRNAs in glioblastoma …

Background Low-grade glioma (LGG) is one of the most common and aggressive
neurological malignant tumors of the central nervous system. Mounting evidence indicates …